Leela Sriram Dodda
About Leela Sriram Dodda
Leela Sriram Dodda is the Director of Computational Chemistry at Nimbus Therapeutics, where she has worked since 2022. She holds a PhD in Physical Chemistry from Yale University and has significant experience in computational chemistry, machine learning, and drug discovery.
Current Position at Nimbus Therapeutics
Leela Sriram Dodda serves as the Director of Computational Chemistry at Nimbus Therapeutics. She has held this position since 2022, contributing to the company's efforts in drug discovery through advanced computational methods. Her role involves overseeing projects that leverage machine learning and cloud-based infrastructure to enhance the efficiency of drug development processes.
Previous Experience in Computational Chemistry
Prior to her current role, Dodda worked at Nimbus Therapeutics as the Associate Director of Computational Chemistry from 2021 to 2023. Before joining Nimbus, she was employed at VantAI as a Computational Chemist and later as Head of Chemistry, where she gained valuable experience in the application of computational techniques in the pharmaceutical industry.
Educational Background in Chemistry
Dodda earned her Doctor of Philosophy (PhD) in Physical Chemistry from Yale University, where she studied from 2013 to 2018. She also completed her Integrated Masters in Chemistry at the National Institute of Science Education and Research in Bhubaneswar, India, from 2008 to 2013. Her educational background provides a strong foundation for her expertise in computational chemistry.
Mentorship and Team Leadership
Leela Sriram Dodda has experience in mentoring teams within the field of computational chemistry. Her leadership skills have been demonstrated through her roles at Nimbus Therapeutics and VantAI, where she guided teams in applying computational methods to solve complex scientific problems.
Research Contributions and Publications
Dodda has a proven track record of contributing to scientific publications and patents in the field of computational chemistry. Her work has advanced the understanding of drug discovery processes and has implications for the development of new therapeutic agents.